Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.52 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.52 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | PYGB | P11216 | 7/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dextrose SCHEMBL8765193 | 1.00 | LGALS1 (0.52) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| Dextrose SCHEMBL28878590 | 0.92 | LGALS3 (0.54) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL10050863 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL6773078 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL10050865 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL23758905 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL16550455 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL20111935 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL21123450 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL13576892 | 0.92 | LGALS3 (0.58) | LGALS1LGALS3LGALS9LGALS8CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107353273-B | The method of luteolin and Rubus corchorifolius element is extracted from Rubus corchorifolius | 抚州市东乡区九鼎牧业有限公司 | 2019-12-03 | — | — | CN | disclosed |
| CN-107501365-A | A kind of method that raspberry glycosides and anthocyanin are extracted from raspberry | 长沙湘资生物科技有限公司 | 2017-12-22 | — | — | CN | disclosed |
| CN-107440929-A | A kind of whitening and skin-protecting product of the strontium containing small peptide | 长沙湘资生物科技有限公司 | 2017-12-08 | — | — | CN | disclosed |
| CN-107417696-A | A kind of method that raspberry glycosides and ellagic acid are extracted from raspberry | 长沙爱扬医药科技有限公司 | 2017-12-01 | — | — | CN | disclosed |
| CN-107353273-A | The method that cyanidenon and Rubus corchorifolius element are extracted from Rubus corchorifolius | 湖南楚宏生物科技有限公司 | 2017-11-17 | — | — | CN | disclosed |
| US-20040076690-A1 | Compositions for weight loss with improved taste | KANEBO, LTD. (JP) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040076690-A1 | Compositions for weight loss with improved taste | FABP4, FABP6, TAS2R60 | LGALS1 74/4885LGALS3 95/4885LGALS9 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.